2023/10/05 by Tianlai Chen, Madeleine Dumas, Chen, Tianlai +38 · 3 voices · 5 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Peptidase Inhibition and Analysis #Protein Degradation and Inhibitors #q-bio.BM #vaccines and immunoinformatics approaches
paper · pdf · doi:10.48550/arxiv.2310.03842
openalex publication_date 2023/10/05 · openalex created_date 2023/10/25 · openalex updated_date 2026/08/01
benchmarking with AlphaFold-Multimer, outperforming RFDiffusion on structured targets, we experimentally verify PepMLM's efficacy via fusion of model-derived peptides to E3 ubiquitin ligase domains, demonstrating endogenous degradation of emergent viral phosphoproteins and Huntington's disease-driving proteins. In total, PepMLM enables the generative design of candidate binders to any target protein, without the requirement of target structure, empowering downstream therapeutic applications.